Immunotherapy Can Boost Survivability
Lung cancer is the leading cause of cancer deaths in industrialized nations, leading ahead of colorectal, breast, and prostate cancer. Dr. Arnold Smith has a long term track record of success in treating lung cancer.
Multiple studies have provided evidence that Cimetidine has a great effect on the immune system and on long term survival in cancer patients. For reasons that do not appear to be in the best interest of patients, Cimetidine is rarely used in the US to treat any form of cancer. Dr. Arnold Smith has placed virtually every patient on Cimetidine after seeing the powerful results of this drug on a twenty-one year survivor of lung cancer, John Reese.
Evidence that a biological approach which had immune stimulation as its fundamental objective was able to benefit cancer patients has been available for over 20 years. It is well to remember that physicians in the business of cancer treatment face financial disincentives preventing the widespread use of immunotherapy, and outcome data which is not in conformance with the current treatment paradigm is ignored or suppressed. Dr. Arnold Smith’s innovative immune strengthening treatments have demonstrated much higher survival rate than those which do not employ immunotherapy.